A股異動 | 太空智造(300344.SZ)復牌跌逾6% 公司實控人及控股股東或變更
格隆匯5月12日丨太空智造(300344.SZ)復牌觸及跌停後回升,現報4.8元,跌幅6.25%,最新總市值23.8億,換手率5%。公司昨日公告稱,擬以3.82元/股向合肥嶺岑科技諮詢合夥企業發行不超1.488億股(佔本次發行前上市公司總股本的30%),募資不超5.69億元,扣除發行費用後,募集資金淨額將全部用於補充流動資金和償還有息負債。此外,寧波嶺楠擬受讓公司實控人出售的6.5%股份,並放棄其剩餘股份表決權。合肥嶺岑與寧波嶺楠受同一控制,完成後合計持有公司發行後28.08%的股份。公司控股股東將變更為合肥嶺岑,實控人變更為古鈺瑭。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.